TWI824269B - Drug distribution system - Google Patents
Drug distribution system Download PDFInfo
- Publication number
- TWI824269B TWI824269B TW110126270A TW110126270A TWI824269B TW I824269 B TWI824269 B TW I824269B TW 110126270 A TW110126270 A TW 110126270A TW 110126270 A TW110126270 A TW 110126270A TW I824269 B TWI824269 B TW I824269B
- Authority
- TW
- Taiwan
- Prior art keywords
- user
- module
- medication
- medicine
- identification
- Prior art date
Links
- 238000009513 drug distribution Methods 0.000 title claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract description 182
- 229940079593 drug Drugs 0.000 claims abstract description 117
- 239000006187 pill Substances 0.000 claims description 36
- 238000012377 drug delivery Methods 0.000 claims description 33
- 239000007924 injection Substances 0.000 claims description 15
- 238000002347 injection Methods 0.000 claims description 15
- 238000007726 management method Methods 0.000 claims description 7
- 230000036541 health Effects 0.000 claims description 6
- 230000009471 action Effects 0.000 claims description 4
- 238000012544 monitoring process Methods 0.000 claims description 3
- 238000013475 authorization Methods 0.000 abstract 2
- 230000005291 magnetic effect Effects 0.000 description 40
- 238000000034 method Methods 0.000 description 11
- 239000000696 magnetic material Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 238000011269 treatment regimen Methods 0.000 description 4
- 238000012864 cross contamination Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005293 ferrimagnetic effect Effects 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 239000003302 ferromagnetic material Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 239000002887 superconductor Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Catching Or Destruction (AREA)
Abstract
Description
本揭露涉及一種藥物配送系統,尤指一種具備模組化藥盒之設計且具有控管使用者身份權限及檢核取藥正確性之雙重機制的藥物配送系統。 The present disclosure relates to a drug delivery system, in particular, a drug delivery system with a modular pill box design and a dual mechanism of controlling user identity and authority and checking the correctness of taking medicine.
慢性病患者須長期用藥以控制病情,故藥物用量多以月為單位計算,惟患者在藥品配給後經常發生忘記用藥份量及用藥時間之問題,進而有不當用藥甚至於影響患者生命安全之情形,且好發於偏遠地區之獨居者。此外,現有之智慧藥盒仍須於患者領藥後,以人為方式將其進行分組並放入藥盒中;然而,患者及其家屬通常不具有醫學或藥理之專業知識,故將藥品錯置分組之可能性高。又,在拆封藥包時,藥品間可能產生交叉污染或受潮等問題。另外,若藥品繁雜且用藥時間皆不同時,患者及其家屬實難根據處方箋排出適當之用藥時間。 Patients with chronic diseases need to take medicines for a long time to control their condition, so the dosage of medicines is usually calculated in monthly units. However, after the medicines are dispensed, patients often forget the dosage and time of taking the medicines, which may lead to improper use of medicines and even affect the patient's life safety. It is more likely to occur in people living alone in remote areas. In addition, existing smart pill boxes still require the patient to manually group the medicines into groups and put them into the medicine box after receiving them; however, patients and their family members usually do not have professional knowledge in medicine or pharmacology, so they misplace the medicines. The possibility of grouping is high. In addition, when unpacking the medicine package, problems such as cross-contamination or moisture may occur between the medicines. In addition, if the medicines are complicated and the medication times are different, it is difficult for patients and their families to determine the appropriate medication time according to the prescription.
另一方面,在救護車接到患者並送往醫院之過程中,救護車上之救護員或自醫院端遠端連線之醫護人員須對患者進行初步診斷與治療。然而,現有急救箱之設計無法於繁雜且急迫之救護流程中供救護員快速找尋並確認所需藥品或針劑,亦無法確實記錄藥品或針劑之使用狀態以輔助醫護人員判讀病況與決策治療方針。 On the other hand, when the ambulance receives the patient and sends him to the hospital, the ambulance attendant or the medical staff connected remotely from the hospital must conduct preliminary diagnosis and treatment of the patient. However, the design of the existing first aid kit cannot allow ambulance personnel to quickly find and confirm the required drugs or injections during the complicated and urgent rescue process, nor can it accurately record the usage status of the drugs or injections to assist medical staff in interpreting the condition and deciding on treatment strategies.
是以,如何提供一種能克服前述問題之藥物配送系統,為目前本領域亟待解決的課題之一。 Therefore, how to provide a drug delivery system that can overcome the aforementioned problems is one of the current issues in this field that needs to be solved urgently.
為解決上述問題,本揭露提供一種藥物配送系統,包括:至少一模組化藥盒,其具有用以容置藥包之複數個格體,其中,該藥包具有識別單元;以及主機單元,其側面與該模組化藥盒結合,且該主機單元包括:儲存模組,用以儲存使用者之用藥資訊;權限控管模組,用以辨識該使用者之身份並查核該用藥資訊以判定該使用者之使用權限,並於判定該使用者具備該使用權限時,開啟該模組化藥盒以供該使用者取得該藥包;及識別模組,用以確認該識別單元與該用藥資訊是否相符。 In order to solve the above problems, the present disclosure provides a drug delivery system, including: at least one modular pill box, which has a plurality of grids for accommodating medicine packages, wherein the medicine package has an identification unit; and a host unit, Its side is combined with the modular pill box, and the host unit includes: a storage module for storing the user's medication information; an authority control module for identifying the user's identity and checking the medication information. Determine the user's usage authority, and when it is determined that the user has the usage authority, open the modular pill box for the user to obtain the medicine package; and identify the module to confirm that the identification unit is consistent with the Whether the medication information is consistent.
於本揭露之藥物配送系統的一些實施態樣中,該主機單元之側面與該模組化藥盒磁性結合。 In some implementations of the drug delivery system of the present disclosure, the side of the host unit is magnetically coupled to the modular pill box.
於本揭露之藥物配送系統的一些實施態樣中,該模組化藥盒具有取藥口,以及該複數個格體能經組合形成一圓柱體,且該圓柱體配置為於該模組化藥盒中可旋轉,以使該複數個格體之其中一者對應該取藥口。 In some implementations of the drug delivery system of the present disclosure, the modular medicine box has a medicine dispensing port, and the plurality of grids can be combined to form a cylinder, and the cylinder is configured to be in the modular medicine box. The box can be rotated so that one of the plurality of grids corresponds to the medicine taking port.
於本揭露之藥物配送系統的一些實施態樣中,該複數個格體可為抽屜結構,且該藥包可為藥品、針劑或其組合。 In some implementations of the drug delivery system of the present disclosure, the plurality of compartments may be drawer structures, and the medicine package may be medicines, injections, or a combination thereof.
於本揭露之藥物配送系統的一些實施態樣中,該識別單元為一維條碼、二維條碼或其組合。 In some implementations of the drug delivery system of the present disclosure, the identification unit is a one-dimensional barcode, a two-dimensional barcode, or a combination thereof.
於本揭露之藥物配送系統的一些實施態樣中,該識別單元之內容包括姓名、身分證字號、生日、性別、藥品名稱、緊急聯絡資訊、用藥時間、病歷號碼、用藥資訊或其中兩者以上之組合。 In some implementations of the drug delivery system of the present disclosure, the content of the identification unit includes name, ID card number, birthday, gender, drug name, emergency contact information, medication time, medical record number, medication information, or more than two of them. combination.
於本揭露之藥物配送系統的一些實施態樣中,該權限控管模組藉由健保卡、指紋、無線射頻辨識晶片或其中兩者以上之組合以進行辨識。 In some implementations of the drug delivery system of the present disclosure, the authority control module performs identification through health insurance cards, fingerprints, radio frequency identification chips, or a combination of two or more thereof.
於本揭露之藥物配送系統的一些實施態樣中,該主機單元更包括:顯示模組,用以於該識別模組確認該識別單元與該用藥資訊相符時,播放用藥教學;記錄模組,用以於該顯示模組播放用藥教學時,記錄該使用者之用藥資訊;提醒模組,用以根據該使用者之用藥資訊送出提醒訊息;警示模組,用以根據該使用者之用藥資訊,於該使用者超過一定時間未取藥或該使用者完成用藥時,藉由網路模組送出警示訊息;上傳模組,用以藉由該網路模組將該使用者之用藥資訊上傳至雲端伺服器;及操作管理模組,用以提供該使用者之用藥資訊之設定、系統狀態之監控與記錄、辨識該使用者身份與該藥包之識別結果之記錄與統計。 In some implementations of the drug delivery system of the present disclosure, the host unit further includes: a display module, used to play medication teaching when the identification module confirms that the identification unit is consistent with the medication information; a recording module, The display module is used to record the user's medication information when playing medication teaching; the reminder module is used to send reminder messages based on the user's medication information; the warning module is used to send reminder messages based on the user's medication information. , when the user has not taken medicine for a certain period of time or when the user has completed taking medicine, a warning message is sent through the network module; the upload module is used to upload the user's medication information through the network module to the cloud server; and the operation management module to provide settings for the user's medication information, monitoring and recording of system status, and recording and statistics of identification results of identifying the user's identity and the medication package.
於本揭露之藥物配送系統的一些實施態樣中,該警示訊息包括APP推播或簡訊。 In some implementations of the drug delivery system of the present disclosure, the warning message includes an APP push or a text message.
於本揭露之藥物配送系統的一些實施態樣中,該使用者之用藥資訊包括使用者身份、藥物資訊、用藥時程限制、緊急聯絡資訊或其中兩者以上之組合。 In some implementations of the drug delivery system of the present disclosure, the user's medication information includes user identity, medication information, medication schedule limits, emergency contact information, or a combination of two or more thereof.
綜上所述,藉由本揭露之藥物配送系統中模組化藥盒之設計,可依據用藥量配置格體數量,並可快速安裝或拆卸於主機單元,從而具備可擴充、靈活調整、易替換及防止藥品間交叉污染和藥品受潮等問題之優點。此外,主機單元具備可控管使用者之身份、記錄用藥過程、提醒與警示等功能,且藥包上具 備識別單元,使得主機單元具備控管使用者身份權限及檢核取藥正確性之雙重機制,故本揭露可有效解決服用藥物種類增加所導致無法從繁雜之處方箋排出正確用藥時間之問題,更可防止使用者誤用藥物之情形。此外,本揭露之藥物配送系統可供救護員在急救過程中快速且正確地使用所需的藥品或針劑,亦可教學及記錄藥品或針劑之使用,以輔助醫師判讀病況及決策治療方針,因此,能在繁雜且緊急的救護流程中使患者得到適當的處置,從而降低延誤急救之風險。 In summary, through the design of the modular pill box in the drug delivery system of the present disclosure, the number of compartments can be configured according to the amount of medication, and can be quickly installed or disassembled on the host unit, thereby being expandable, flexibly adjusted, and easy to replace. And it has the advantages of preventing cross-contamination between medicines and medicines getting damp. In addition, the host unit has functions such as controlling the user's identity, recording the medication process, reminders and warnings, and the medicine package has Equipped with an identification unit, the host unit has a dual mechanism to control the user's identity authority and check the correctness of taking medicines. Therefore, this disclosure can effectively solve the problem of being unable to sort out the correct medication time from the complicated prescription note due to the increase in the types of medicines taken. It can also prevent users from misusing drugs. In addition, the drug delivery system disclosed in the present disclosure can allow rescuers to quickly and correctly use the required drugs or injections during the first aid process, and can also teach and record the use of drugs or injections to assist doctors in interpreting disease conditions and deciding on treatment strategies. Therefore, , which can enable patients to receive appropriate treatment during complex and emergency rescue procedures, thereby reducing the risk of delayed first aid.
1:藥物配送系統 1:Drug delivery system
10:模組化藥盒 10: Modular pill box
11,11’:格體 11,11’:Grid body
12:取藥口 12:Medicine taking port
13:側蓋 13:Side cover
20:主機單元 20:Host unit
201:儲存模組 201:Storage module
202,202’:權限控管模組 202,202’:Permission control module
203:識別模組 203:Identification module
204:顯示模組 204:Display module
205:記錄模組 205:Recording module
206:提醒模組 206:Reminder module
207:警示模組 207:Alert module
208:上傳模組 208:Upload module
209:網路模組 209:Network module
210:操作管理模組 210: Operation management module
30:藥包 30: Medicine bag
31:識別單元 31:Identification unit
40、40’:磁性元件 40, 40’: Magnetic components
圖1為本揭露其中一些實施例之藥物配送系統之系統架構圖。 Figure 1 is a system architecture diagram of a drug delivery system according to some embodiments of the present disclosure.
圖2為本揭露其中一些實施例之藥物配送系統之整體結構示意圖。 Figure 2 is a schematic diagram of the overall structure of a drug delivery system according to some embodiments of the present disclosure.
圖3為本揭露其中一些實施例之模組化藥盒之結構示意圖。 Figure 3 is a schematic structural diagram of a modular pill box according to some embodiments of the present disclosure.
圖4為本揭露其中另一些實施例之藥物配送系統之整體結構示意圖。 Figure 4 is a schematic diagram of the overall structure of a drug delivery system according to other embodiments of the present disclosure.
以下藉由特定之具體實施例加以說明本揭露之實施方式,本揭露所屬技術領域中具有通常知識者可根據本文所揭露之內容輕易地瞭解本揭露之優點和功效。然而,本文所載之具體實施例並非用以限定本揭露,本揭露亦可藉由其他不同之實施方式加以施行或應用,本文所載各項細節亦可根據不同的觀點與應用,在不悖離本揭露之範圍下賦予不同的變化或修飾。 The implementation of the present disclosure will be described below through specific embodiments. Those with ordinary knowledge in the technical field to which the present disclosure belongs can easily understand the advantages and effects of the present disclosure based on the content disclosed herein. However, the specific embodiments contained in this article are not intended to limit the present disclosure. The present disclosure can also be implemented or applied through other different implementations. The various details contained in this article can also be based on different viewpoints and applications, without prejudice to Various changes or modifications may be made without departing from the scope of this disclosure.
本文所附圖式中顯示之比例、結構、大小等特徵,僅用於配合本文所揭示之內容,以供本揭露所屬技術領域中具有通常知識者閱讀及瞭解本揭露, 而非用以限定本揭露可實施之範圍,故任何比例關係之改變、結構之修飾、或大小之調整,在不影響本揭露所能達成之目的及所能產生之功效的條件下,均應屬於本文所揭示之技術內容所能涵蓋的範圍。 The proportions, structures, sizes and other features shown in the drawings attached hereto are only used to coordinate with the content disclosed herein, so that persons with ordinary knowledge in the technical field to which this disclosure belongs can read and understand this disclosure. It is not intended to limit the scope of implementation of the present disclosure. Therefore, any changes in proportions, structural modifications, or size adjustments should be made without affecting the purpose and effects that the disclosure can achieve. It falls within the scope of the technical content disclosed in this article.
本文所述「包括」、「包含」或「具有」特定要件時,除非另有說明,否則可另包括其他元件、組成分、結構、區域、部位、裝置、系統、步驟、連接關係等要件,而非排除該等其他要件。 When "comprising", "comprising" or "having" specific elements are mentioned in this article, unless otherwise stated, other elements, components, structures, regions, locations, devices, systems, steps, connection relationships and other elements may also be included. rather than excluding such other requirements.
此外,除非本文另有明確說明,否則本文所述單數形式之「一」及「該」包括複數形式,且本文所述「或」可與「及/或」互換使用。 In addition, unless otherwise expressly stated herein, the singular forms "a", "an" and "the" used herein include plural referents, and the words "or" used herein are interchangeable with "and/or".
請同時參閱圖1及圖2,本揭露之藥物配送系統1包括至少一模組化藥盒10及主機單元20。於本揭露之至少一具體實施例中,模組化藥盒10具有複數個格體11,而各格體11可分別用以容置一藥包30;另外,模組化藥盒10可與主機單元20之側面結合。於本揭露之至少一具體實施例中,模組化藥盒10之數量可為單個且與主機單元20之一側面結合;於本揭露之一些具體實施例中,模組化藥盒10之數量亦可為二個且分別與主機單元20之二側面結合,或將二個模組化藥盒10彼此堆疊後與主機單元20之一側面結合,或者亦可將主機單元20之二側面分別與堆疊之模組化藥盒10結合。本揭露並未限制模組化藥盒10之數量及其結合於主機單元20之可能實施態樣。
Please refer to FIG. 1 and FIG. 2 simultaneously. The
如圖2所示,於本揭露之至少一具體實施例中,模組化藥盒10可具有一取藥口12。於本揭露之至少一具體實施例中,複數個格體11可例如為扇形柱體,以於複數個格體11組合後構成一圓柱體,該圓柱體可藉由致動器驅動(例如藉由伺服馬達控制等)於模組化藥盒10中旋轉,以使複數個格體11其中之一者對應取藥口12,俾利於使用者藉由取藥口12取得藥包30。
As shown in FIG. 2 , in at least one embodiment of the present disclosure, the
於本揭露之至少一具體實施例中,複數個格體11之數量可依據需求設計,例如患者每天需服用4包藥量,則複數個格體11可設計成28格(一週藥量)或56格(二週藥量),但本揭露並不以此為限。
In at least one specific embodiment of the present disclosure, the number of the plurality of
於本揭露之至少一具體實施例中,主機單元20可與模組化藥盒10磁性結合。本文中的術語「磁性結合」是指複數個元件之間藉由磁吸力連接、黏合、接合、扣合或附著在一起,其包括「直接的磁性結合」及「間接的磁性結合」。
In at least one specific embodiment of the present disclosure, the
如本文中所述,術語「直接的磁性結合」是指複數個元件之間彼此產生磁吸力而結合。於本揭露之至少一具體實施例中,主機單元20與模組化藥盒10之其中一者包含磁源,而主機單元20和模組化藥盒10之其中另一者則包含磁源或磁性物質,該磁源之間或該磁源與磁性物質之間的磁吸力使得主機單元20與模組化藥盒10可以結合。
As used herein, the term "direct magnetic coupling" refers to the coupling of multiple components through magnetic attraction to each other. In at least one embodiment of the present disclosure, one of the
本文中的術語「磁源」是指自然地或可經感應而產生磁場的材料,其包括但不限於磁鐵、電磁鐵及超導體。於本揭露之至少一具體實施例中,磁源為磁鐵,例如可為強力磁鐵。 The term "magnetic source" as used herein refers to materials that generate magnetic fields naturally or through induction, including but not limited to magnets, electromagnets, and superconductors. In at least one embodiment of the present disclosure, the magnetic source is a magnet, such as a powerful magnet.
本文中的術語「磁性物質」是指在外部磁場作用下得以被磁化的材料,其包括但不限於鐵磁性物質、亞鐵磁性物質、順磁性物質、超順磁性物質或其中兩者以上之組合。於本揭露之至少一具體實施例中,磁性物質為鐵磁性物質,例如但不限於鐵。 The term "magnetic substance" in this article refers to materials that are magnetized under the action of an external magnetic field, including but not limited to ferromagnetic substances, ferrimagnetic substances, paramagnetic substances, superparamagnetic substances or a combination of two or more thereof . In at least one embodiment of the present disclosure, the magnetic material is a ferromagnetic material, such as but not limited to iron.
如本文中所述,術語「間接的磁性結合」是指複數個元件之間藉由至少一連結件產生磁吸力而結合。於本揭露之一具體實施例中,主機單元20與模組化藥盒10之其中一者包含磁源,而主機單元20與模組化藥盒10之其中另一者則設置有包含磁源或磁性物質的連結件,該磁源及該包含磁源或磁性物質的連結
件之間的磁吸力使得主機單元20與模組化藥盒10可以結合。於本揭露之一些具體實施例中,主機單元20與模組化藥盒10之其中一者設置有包含磁源的連結件,而主機單元20與模組化藥盒10之其中另一者則設置有包含磁源或磁性物質的連結件,該包含磁源的連結件及該包含磁源或磁性物質的連結件之間的磁吸力使得主機單元20與模組化藥盒10可以結合。於本揭露之一些具體實施例中,主機單元20與模組化藥盒10之其中一者設置有包含磁源的連結件,而主機單元20與模組化藥盒10之其中另一者則包含磁源或磁性物質,該包含磁源的連結件及該磁源或磁性物質之間的磁吸力使得主機單元20與模組化藥盒10可以結合。
As described herein, the term "indirect magnetic coupling" refers to the coupling between multiple components through magnetic attraction generated by at least one connecting member. In a specific embodiment of the present disclosure, one of the
於本揭露之至少一具體實施例中,連結件為磁性元件40、40’。如圖2所示,模組化藥盒10之一面可藉由磁性元件40’與主機單元20之側面磁性結合,而模組化藥盒10之另一面亦可藉由磁性元件40與一側蓋13磁性結合,其中側蓋13用以防止複數個格體11內之藥包30掉落。磁性元件40、40’可為強力磁鐵,以易於模組化藥盒10的拆裝,並便於在卸除側蓋13後補充藥包30(如圖3所示),但本揭露並不以此為限。
In at least one embodiment of the present disclosure, the connecting elements are
於本揭露之至少一具體實施例中,如圖3所示,藥包30具有一識別單元31,識別單元31可為一維條碼(barcode)或二維條碼(例如QR Code),但本揭露並不以此為限。於本揭露之至少一具體實施例中,識別單元31之內容可包括姓名、身分證字號、生日、性別、藥品名稱、緊急聯絡資訊、用藥時間、病歷號碼及用藥資訊等,但本揭露亦不以此為限。
In at least one specific embodiment of the present disclosure, as shown in FIG. 3 , the
於本揭露之至少一具體實施例中,如圖1及圖2所示,主機單元20可包括儲存模組201、權限控管模組202、202’及識別模組203。儲存模組201用以儲存使用者之用藥資訊,例如儲存模組201可為硬碟、記憶體或快閃記憶體,且不
以此為限。權限控管模組202、202’用以識別使用者之身份並查核用藥資訊,以決定使用者是否具備使用權限,例如權限控管模組202可為健保卡讀取器,以藉由讀取健保卡而識別使用者之身份;又例如權限控管模組202’可為無線射頻辨識(Radio Frequency Identification,RFID)讀取器,以藉由無線射頻辨識晶片識別使用者之身份。另外,權限控管模組202、202’亦可為指紋辨識器,使用者之指紋可事先儲存於儲存模組201中,以藉由指紋識別使用者之身份。
In at least one specific embodiment of the present disclosure, as shown in FIGS. 1 and 2 , the
於本揭露之至少一具體實施例中,使用者之用藥資訊包括使用者身份、藥物資訊、用藥時程限制及緊急聯絡資訊,此些資訊可事先輸入(例如藉由後述之操作管理模組210)並儲存於儲存模組201中。權限控管模組202、202’之運作則是在藉由健保卡、指紋或無限射頻辨識晶片取得使用者之身份後,比對儲存於儲存模組201中使用者之用藥資訊中的使用者身份,以決定使用者是否具備使用權限,例如藉由健保卡取得使用者之名字及身分證字號,並比對使用者之用藥資訊中是否具有相同之名字及身分證字號。若使用者具備使用權限,權限控管模組202、202’將開啟模組化藥盒10以供使用者取得藥包30,或者可於開啟模組化藥盒10之後,旋轉到指定格體11,以供使用者取得指定格體11內的特定藥包30。若使用者不具備使用權限,則權限控管模組202、202’將鎖住模組化藥盒10,以避免使用者取得藥包,例如控制沒有裝填藥包30之格體11一直維持在取藥口12,或於取藥口12加裝電子鎖。
In at least one specific embodiment of the present disclosure, the user's medication information includes user identity, medication information, medication schedule limits and emergency contact information. This information can be input in advance (for example, through the
於本揭露之至少一具體實施例中,在使用者取得藥包30之後,使用者可再藉由識別模組203識別藥包30上的識別單元31,以確認識別單元31之資訊與儲存模組201中所儲存之使用者之用藥資訊是否相符。於本揭露之至少一具體實施例中,識別模組203可為QR Code讀取器,而為確認識別單元31之內容與使用
者之用藥資訊是否相符,可比對識別單元31之內容中的姓名、藥品名稱、用藥時間或用藥資訊與使用者之用藥資訊中的使用者身份、藥物資訊或用藥時程限制是否相符,此是為了確保使用者所取得之藥包30確實為使用者本人所需,以防止藥包30於補充時可能發生之補充錯誤而導致使用者誤取藥物。於本揭露之至少一具體實施例中,識別模組203可確認使用者在進行識別藥包30上的識別單元31時之時間是否在用藥時間內,以防止使用者在非規定時間內用藥。在確定藥包30確實為本人領取後,主機單元20之顯示模組204上可播放用藥教學,例如以若干步驟指示使用者用藥動作。
In at least one specific embodiment of the present disclosure, after the user obtains the
於本揭露之至少一具體實施例中,主機單元20可包括記錄模組205,用以於顯示模組204播放用藥教學時,記錄使用者之用藥資訊,例如記錄模組205可為攝影機,故記錄使用者用藥資訊之方式即為拍成影片,而影片則可儲存在儲存模組201中。
In at least one specific embodiment of the present disclosure, the
於本揭露之至少一具體實施例中,主機單元20可包括提醒模組206,用以根據使用者之用藥資訊送出提醒訊息。提醒模組206可為主機單元20內微處理器所運行之軟體功能,其可根據使用者之用藥資訊中的用藥時程限制以送出提醒訊息,例如於使用者用藥前30分鐘以聲響或燈光等方式提醒使用者即將用藥。
In at least one specific embodiment of the present disclosure, the
於本揭露之至少一具體實施例中,主機單元20可包括警示模組207,用以根據使用者之用藥資訊,於使用者超過一定時間未取藥或使用者完成用藥時,藉由網路模組209送出警示訊息。警示模組207可為主機單元20內微處理器所運行之軟體功能,警示訊息可為APP推播(例如Line群組推播等)或簡訊,
而網路模組209可為3G、4G、5G或WiFi等無線網路。另外,警示訊息可藉由網路模組209通知醫院及相關人員,以便於後續追蹤。
In at least one specific embodiment of the present disclosure, the
於本揭露之至少一具體實施例中,主機單元20可包括上傳模組208,用以藉由網路模組209將使用者之用藥資訊上傳至雲端伺服器(未圖示)。另外,主機單元20可更包括操作管理模組210,用以提供使用者用藥資訊之設定、系統狀態之監控與記錄、辨識使用者身份與藥包識別結果之記錄與統計。上述之上傳模組208及操作管理模組210可為主機單元20內微處理器所運行之軟體功能,或是顯示於顯示模組204上之使用者界面,而顯示模組204可為螢幕或觸控式面板。
In at least one specific embodiment of the present disclosure, the
請參閱圖4,於一些具體實施例中,本揭露之模組化藥盒10中格體11’之實施態樣亦可為抽屜結構,這使得格體11’可放置之藥包可包括藥品與針劑。因此,本實施例之藥物配送系統1可設置於救護車上,並於模組化藥盒10中不同之格體11’內放置不同急救步驟所需之針劑與藥包。在使用時,藉由主機單元20之權限控管模組202及識別模組203確定救護員的權限與所需之針劑,並可利用顯示模組204與記錄模組205進行教學與記錄針劑施打動作、針劑類型或針劑劑量等資訊。本實施例之藥物配送系統1可使患者在繁雜且緊急的救護流程中得到適當的處置,亦能輔助醫生判讀病況與決策治療方針,進而降低延誤急救之風險。
Please refer to Figure 4. In some specific embodiments, the implementation mode of the compartment 11' in the
綜上所述,藉由本揭露之藥物配送系統1中模組化藥盒10之設計,可依據用藥量配置格體11數量,並可快速拆裝於主機單元20,從而具備可擴充、靈活調整、易替換及防止藥品間交叉污染和藥品受潮等問題之優點。此外,主機單元20具備可控管使用者之身份、記錄用藥過程、提醒與警示等功能,且藥包30
上具備識別單元31,使得主機單元20具備控管使用者身份權限及檢核取藥正確性之雙重機制,故本揭露可有效解決服用藥物種類增加而導致無法從繁雜之處方箋排出正確用藥時間之問題,更可防止使用者誤用藥物之情形。此外,本揭露之藥物配送系統1可供救護員在急救過程中快速且正確地使用所需的藥品或針劑,亦可教學及記錄藥品或針劑之使用,以輔助醫師判讀病況及決策治療方針,因此,能在繁雜且緊急的救護流程中使患者得到適當的處置,從而降低延誤急救之風險。
In summary, through the design of the
上述實施形態僅為例示性說明本揭露之技術原理、特點及其功效,並非用以限制本揭露可實施之範圍,本揭露所屬技術領域中具有通常知識者均可在不違背本揭露之範圍下,對上述實施形態進行修飾與改變。然而,任何運用本揭露所教示內容而完成之等效修飾及改變,均仍應為下述之申請專利範圍所涵蓋,故本揭露之權利保護範圍應將如下述之申請專利範圍所列。 The above embodiments are only illustrative to illustrate the technical principles, features and effects of the present disclosure, and are not intended to limit the scope of the present disclosure. Anyone with ordinary knowledge in the technical field to which the present disclosure belongs can make various modifications without departing from the scope of the present disclosure. , modify and change the above embodiment. However, any equivalent modifications and changes accomplished by applying the teachings of this disclosure should still be covered by the following patent application scope, and therefore the scope of rights protection of this disclosure should be as listed in the following patent application scope.
1:藥物配送系統 1:Drug delivery system
10:模組化藥盒 10: Modular pill box
11:格體 11: grid body
20:主機單元 20:Host unit
201:儲存模組 201:Storage module
202:權限控管模組 202:Permission control module
203:識別模組 203:Identification module
204:顯示模組 204:Display module
205:記錄模組 205:Recording module
206:提醒模組 206:Reminder module
207:警示模組 207:Alert module
208:上傳模組 208:Upload module
209:網路模組 209:Network module
210:操作管理模組 210: Operation management module
30:藥包 30: Medicine bag
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW110126270A TWI824269B (en) | 2021-07-16 | 2021-07-16 | Drug distribution system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW110126270A TWI824269B (en) | 2021-07-16 | 2021-07-16 | Drug distribution system |
Publications (2)
Publication Number | Publication Date |
---|---|
TW202304404A TW202304404A (en) | 2023-02-01 |
TWI824269B true TWI824269B (en) | 2023-12-01 |
Family
ID=86661510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW110126270A TWI824269B (en) | 2021-07-16 | 2021-07-16 | Drug distribution system |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI824269B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWM360042U (en) * | 2009-03-13 | 2009-07-01 | rui-ming Zhou | Device for offering audio/video medical information and medicine bag with the device |
CN105106018A (en) * | 2015-05-27 | 2015-12-02 | 顾振宇 | Medicine box, medicine intake management device, terminal system and method |
TWM568706U (en) * | 2018-08-14 | 2018-10-21 | 王俊棋 | Speech recognition medication reminder system |
US20190336399A1 (en) * | 2018-05-03 | 2019-11-07 | Compliance Meds Technologies Llc | Modular multi-compartment drug dispensing apparatus |
-
2021
- 2021-07-16 TW TW110126270A patent/TWI824269B/en active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWM360042U (en) * | 2009-03-13 | 2009-07-01 | rui-ming Zhou | Device for offering audio/video medical information and medicine bag with the device |
CN105106018A (en) * | 2015-05-27 | 2015-12-02 | 顾振宇 | Medicine box, medicine intake management device, terminal system and method |
US20190336399A1 (en) * | 2018-05-03 | 2019-11-07 | Compliance Meds Technologies Llc | Modular multi-compartment drug dispensing apparatus |
TWM568706U (en) * | 2018-08-14 | 2018-10-21 | 王俊棋 | Speech recognition medication reminder system |
Also Published As
Publication number | Publication date |
---|---|
TW202304404A (en) | 2023-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11188873B2 (en) | Remotely-executed medical therapy device | |
WO2016188479A1 (en) | Medical kit for medicine taking management, device, terminal thereof, system and method | |
EP1721596B1 (en) | Patient controlled timed medication dispenser | |
US10285904B2 (en) | Medication guidance system and method | |
US8544646B2 (en) | Medical safety box | |
US9875666B2 (en) | Apparatus and method for recognition of patient activities | |
US10709643B2 (en) | Tamper-proof pill dispensing system and methods of use | |
US20060079994A1 (en) | Unit-dose medication dispensing cart and method of operating the same | |
US20180333860A1 (en) | System and method for prescription medicine delivery | |
CN101802830A (en) | Operation of a remote medication management system | |
CN103108617B (en) | Intelligent first-aid kit | |
WO2016141102A1 (en) | System and device for dispensing medications and remotely monitoring health systems | |
US20220319659A1 (en) | Devices and methods for security and tracking of items | |
TWM594251U (en) | Drug management cabinet | |
KR20160146470A (en) | Blister package and manufacturing method thereof | |
Chang et al. | Implement the RFID position based system of automatic tablets packaging machine for patient safety | |
JP2012527925A (en) | Device with electromechanical lock for safe distribution of blood or blood components | |
TWI824269B (en) | Drug distribution system | |
US10632046B2 (en) | Medication guidance system | |
TWI453690B (en) | Smart medical cabinet system | |
Pinto et al. | A review of current pill organizers and dispensers | |
US20210065866A1 (en) | Smart medication container | |
WO2022049499A1 (en) | Smart medication container | |
TWM616937U (en) | Drug identification system prior to administration of drug | |
TW202244939A (en) | Drug identification system before administering drugs |